Value8 NV
Value8 NV is a Dutch listed investment company on Euronext Amsterdam that acquires, finances, and grows small and medium-sized enterprises in healthcare and IT sectors, serving as a public-equity vehicle for investors seeking exposure to a diversified Dutch SMB portfolio.
- Company typePublic
- Founded2008
- HeadquartersBussum, Netherlands
- Headcount501–1,000
- GTM typeB2B
- OfferingServices
What Value8 NV does
Value8 NV is a Netherlands-based listed investment company (investeringsmaatschappij) trading on Euronext Amsterdam (ordinary shares ISIN: NL0010661864) that builds and grows publicly tradable Dutch small and medium-sized companies alongside their entrepreneurs and management teams. Founded in 2008 (originally as Exendis NV, which dates to 1939), the firm focuses its capital on two sectors — healthcare and information technology — that benefit from demographic and digitalisation megatrends. Value8 holds controlling or significant stakes in Ctac (66.9%, IT services and Business & Cloud Integrator for SAP and Microsoft), Kersten/Morefield Group (medical aids, including the Naviva Kraamzorg maternity-care acquisition), Almunda Professionals' PIDZ and Novisource (healthcare staffing and financial-sector consultancy), and a 31% interest in Deal Value Group (Brookz/Dealsuite, an online SMB M&A platform). It also holds minority listed equity, including historically in waste-recycler Renewi (exited via Macquarie in 2025).
Value8 generates revenue through dividends from portfolio companies, interest on loans to those companies, realised and unrealised gains on quoted and unquoted investments, and proceeds from divestments (for example, AmsterdamGold sold in September 2024 for €6.2M and Fund Solutions in June 2024 for €2.5M). Operating income was €8.2M (2023) and €9.6M preliminary (2024); net profit reached €7.1M in 2024. The capital base is exceptionally strong — equity crossed €100M for the first time in 2024 to reach €108.9M by H1 2025, with solvency at 93.7% — supporting an unbroken dividend track record since 2011 and the recent €3.50/share mandatory bid that consolidated ownership in Ctac.
Value8 NV firmographics
Firmographics- Name
- Value8 NV
- Legal name
- Value8 NV
- Website
- https://value8.com
- Company type
- Public
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Value8 NV is a Dutch listed investment company on Euronext Amsterdam that acquires, finances, and grows small and medium-sized enterprises in healthcare and IT sectors, serving as a public-equity vehicle for investors seeking exposure to a diversified Dutch SMB portfolio.
- Ownership category
- akta.pro rank
Value8 NV industry classification
Industry- Product category
- Private Equity / Investment Holding
- NAICS
- Funds, Trusts, and Other Financial Vehicles (525), Other Financial Vehicles (52599)
- SIC
- Security Brokers, Dealers & Flotation Companies (6211)
- akta.pro primary industry
- Strategic / Balance-Sheet CVC (On-balance-sheet investing) (FSANAHAA)
- akta.pro secondary industry
- SME Term Loans & Growth Capital (FSAKAGAB)
Keywords
Where Value8 NV is headquartered
LocationHeadquarters
- HQ city
- Bussum
- HQ country
- Netherlands
- HQ region
- Europe
Offices1 record
Markets served
Value8 NV business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Others, Marketing or Sales, Infrastructure
Revenue model
- Dividend income: Value8 receives dividends from its portfolio companies including Ctac, Morefield/Kersten, Almunda Professionals, and others. The company has paid dividends every year since 2011, with total dividends of €3.54 per ordinary share paid from 2011 to 2025.
- Capital gains on investments: Value8 generates capital gains on both listed and unlisted investments. Realised gains on quoted investments were €4.3 million and on unquoted investments €0.4 million in 2023. Total reële waarde stijging (fair value increase) was €3.9 million in 2024.
- Interest income: Value8 earns interest on loans provided to portfolio companies and other receivables. Interest income rose from €0.79 million in 2023 to €1.21 million in 2024.
- Exit proceeds from desinvestments: Value8 exits investments through trade sales or IPOs. Sold AmsterdamGold in September 2024 for €6.2 million (achieving ~9.5% annual return since 2011). Sold Fund Solutions in June 2024 for €2.5 million.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Value8 NV product offering
Product offeringCore offering
Value8 NV is a Dutch listed investment company that builds growing listed SMB companies together with entrepreneurs and managers. The company acquires equity stakes (majority and minority) in Dutch SMB companies primarily in healthcare and information technology, providing growth capital and strategic support. Value8 earns returns through dividends, interest income, capital gains, and exits via trade sales or IPOs, and has paid annual dividends every year since 2011.
Product overview
Value8 NV is an investment company (investeringsmaatschappij) listed on Euronext Amsterdam that builds growing listed SME companies with excellent entrepreneurs and managers. The company focuses on long-term value creation in the healthcare and information technology sectors. Value8's portfolio consists of investment holdings rather than a unified product platform. Key portfolio companies include Ctac (IT services with SAP/Microsoft solutions and the XV Retail Suite), Kersten/Morefield Group (medical aids), PIDZ (healthcare professionals platform), and Almunda Professionals (professional services including Novisource and ICE).
Differentiator
Problem solved
Functional benefit
Products and services
- Value8 Investment Management Services Long-term equity investment management services that build growing listed SMB companies together with entrepreneurs and managers. Value8 acquires majority or minority stakes in Dutch companies and provides growth capital, strategic guidance, and acquisition financing.
- Ctac
Quantifiable outcome
- NAV per share grew from €0.41 (September 2008) to €11.31 (2025), a 1400% increase
- +3 more outcomes
Companies that use Value8 NV
Customer profileNamed customers4 records
Segments1 record
Ideal customer profiles2 records
Value8 NV technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Value8 NV partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered minor.
- ABN AMRO Bank N.V.minorABN AMRO Bank N.V. acted as the paying and exchange agent (betaal- en verwisselkantoor) for Value8's mandatory public bid on Ctac shares. ABN AMRO provides corporate broking services and was designated to distribute the offer document free of charge to those who requested it, in coordination with Value8's registered office in Bussum.
- Atoz Services S.A.minorBK Group (a Value8 portfolio company) agreed to sell 100% of its shares in Fund Solutions S.C.A. to Atoz Services S.A., a Luxembourg-based professional services firm providing business and tax services to entities managed by alternative funds and corporate clients. The transaction was completed above book value and had a small positive effect on Value8's NAV per share. Completion was subject to CSSF approval. This was a one-time exit transaction; Fund Solutions was subsequently desinvested.
Scale indicators14 records
Recent moves8 records
Expansion highlights5 records
Value8 NV competitors and assessment
Company assessmentDirect peers
- HAL Holding / HAL Trust: HAL Trust is a Dutch-listed holding company that invests in mid-market companies across sectors including healthcare, IT services, and industrial goods. Closest structural analog to Value8: listed permanent-capital vehicle with concentrated Dutch/Benelux deal sourcing and long-hold strategy.
- Kinnevik: Kinnevik is a Swedish-listed investment company with growth-stage and listed-equity exposure focused on consumer internet, financial services, and healthcare. Comparable structural model with listed-permanent-capital approach, though tilted toward earlier-stage consumer/internet rather than Dutch SMB buyouts.
- Gimv: Gimv is a Belgian-listed investment company investing in mid-cap companies across healthcare, technology, and consumer. Same structural model as Value8 (listed permanent-capital PE/VC) and directly comparable in mid-market healthcare and IT focus, with somewhat larger portfolio scale.
- Deutsche Beteiligungs AG (DBAG): DBAG is a German-listed private equity firm focused on mid-market companies in industrial, IT, and healthcare sectors. Same mid-market listed-PE structure as Value8, with comparable average ticket sizes and a similar buy-and-hold-to-delist approach in target companies.
- Sofina: Sofina is a Belgian-listed investment company focused on growth-stage investments in consumer, healthcare, and digital transformation. Shares Value8's listed long-term holding structure, thematic healthcare/IT focus, and minority-to-control ownership style in mid-sized European companies.
- Exor N.V. Exor is an Italian-listed holding company with controlling stakes in Stellantis, Ferrari, and other large enterprises. Operates Value8's same listed-vehicle structure for principal investing, but at far larger scale and focused on global blue-chip companies rather than Dutch SMBs.
- Eurazeo: Eurazeo is a French-listed global investment company with mid-market PE, growth, and private debt strategies. Shares Value8's listed-permanent-capital model and focus on mid-sized European companies, though larger and more diversified by sector and geography.
Broad incumbents
- 3i Group: 3i Group is a UK-listed PE firm with large mid-market buyout and infrastructure strategies. Structural analog (listed-PE model) but operates at far greater scale and focuses on larger pan-European/global deals rather than Dutch SMBs.
- CVC Capital Partners: CVC is a global large-cap private equity firm that listed on Euronext Amsterdam in 2024. Shares Value8's Euronext-Amsterdam listing and PE business model, but operates at vastly greater scale with global deal sourcing rather than Dutch SMB focus.
Regional players
- Waterland Private Equity: Waterland is a privately-held Benelux-focused mid-market private equity firm investing in healthcare, IT, and business services. Directly competes with Value8 for the same Dutch/Benelux SMB deal pool but operates a traditional closed-end fund structure rather than the listed-permanent-capital model.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Value8 NV social profiles
Digital presenceValue8 NV financial estimates
Financial estimateRevenue estimate
Valuation estimate
Value8 NV leadership team
Management profileNumber of profiles
Profiles4 records
Value8 NV subsidiaries and ownership
Company hierarchySubsidiaries4 records
Value8 NV funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Value8 NV M&A and investment
M&A and investmentM&A1 record
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Value8 NV
What does Value8 NV do?
Value8 NV is a Dutch listed investment company that builds growing listed SMB companies together with entrepreneurs and managers. The company acquires equity stakes (majority and minority) in Dutch SMB companies primarily in healthcare and information technology, providing growth capital and strategic support. Value8 earns returns through dividends, interest income, capital gains, and exits via trade sales or IPOs, and has paid annual dividends every year since 2011.
Is Value8 NV a public or private company?
Value8 NV is a public company. It is classified as public and is currently operating.
When was Value8 NV founded?
Value8 NV was founded in 2008. It employs 501 to 1,000 people.
Where is Value8 NV based?
Value8 NV is headquartered in Bussum, Netherlands, in the Europe region.
How does Value8 NV make money?
Four revenue lines are on record. Dividend income is the primary driver. The others are capital gains on investments, interest income and exit proceeds from desinvestments.
Who are Value8 NV's main competitors?
Direct peers on record are HAL Holding / HAL Trust, Kinnevik, Gimv, Deutsche Beteiligungs AG (DBAG), Sofina, Exor N.V. and Eurazeo. Broad incumbents are 3i Group and CVC Capital Partners. Waterland Private Equity is listed as a regional player.
Does Value8 NV have an API?
No public API is recorded for Value8 NV.
What industry is Value8 NV in?
Value8 NV's product category is Private Equity / Investment Holding. Its primary akta.pro industry code is FSANAHAA, Strategic / Balance-Sheet CVC (On-balance-sheet investing), with a secondary code of FSAKAGAB, SME Term Loans & Growth Capital. Its NAICS code is 525 and its SIC code is 6211.